MEDICOVER AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 132.4 SEK | 0.00% |
|
-5.70% | -11.79% |
| Feb. 09 | Nordic Shares Moved Upward Friday; Kongsberg Gruppen Topped Leaders | DJ |
| Feb. 09 | Transcript : Medicover AB, Q4 2023 Earnings Call, Feb 09, 2024 |
| Sales 2024 * | 2.02B 2.16B 23.51B | Sales 2025 * | 2.33B 2.49B 27.19B | Capitalization | 1.69B 1.81B 19.74B |
|---|---|---|---|---|---|
| Net income 2024 * | 23M 24.57M 268M | Net income 2025 * | 54M 57.69M 629M | EV / Sales 2024 * | 1.35 x |
| Net Debt 2024 * | 1.02B 1.09B 11.9B | Net Debt 2025 * | 1.13B 1.21B 13.15B | EV / Sales 2025 * | 1.21 x |
| P/E ratio 2024 * |
66.6
x | P/E ratio 2025 * |
31.4
x | Employees | 45,316 |
| Yield 2024 * |
1.06% | Yield 2025 * |
1.18% | Free-Float | 40.99% |
More Fundamentals
* Assessed data
More news
Latest transcript on Medicover AB
More news
| 1 day | -0.23% | ||
| 1 week | -5.98% | ||
| Current month | -4.35% | ||
| 1 month | -2.08% | ||
| 3 months | -15.60% | ||
| 6 months | +6.88% | ||
| Current year | -12.06% |
1 week
131.00
143.60
1 month
131.00144.80
Current year
131.00188.40
1 year
118.30188.40
3 years
109.90372.00
5 years
71.50372.00
10 years
57.25372.00
| Managers | Title | Age | Since |
|---|---|---|---|
Fredrik Rågmark
CEO | Chief Executive Officer | 61 | 94-12-31 |
Joe Ryan
DFI | Director of Finance/CFO | 59 | 95-12-31 |
| Chief Tech/Sci/R&D Officer | 73 | 17-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fredrik Rågmark
CEO | Chief Executive Officer | 61 | 94-12-31 |
| Director/Board Member | 84 | 06-12-31 | |
Arno Bohn
BRD | Director/Board Member | 77 | 00-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.11% | 5 M€ | +6.38% | ||
| 0.02% | 773 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 132.4 | 0.00% | 120 481 |
| 24-04-17 | 132.4 | -1.19% | 165,269 |
| 24-04-16 | 134 | -2.33% | 153,489 |
| 24-04-15 | 137.2 | +1.03% | 120,060 |
| 24-04-12 | 135.8 | -3.28% | 119,939 |
Delayed Quote Nasdaq Stockholm, April 18, 2024 at 03:27 am EDT
More quotes
Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The Company offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover's own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The Company focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
11.32
EUR
Average target price
16.97
EUR
Spread / Average Target
+49.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.06% | 1.8B | |
| +14.91% | 82.27B | |
| +11.06% | 29.43B | |
| -12.02% | 16.82B | |
| -5.02% | 15.89B | |
| -7.91% | 14.1B | |
| -0.27% | 12.05B | |
| -29.65% | 12.01B | |
| +21.84% | 11.19B | |
| -5.85% | 11.09B |
- Stock Market
- Equities
- MCOV B Stock
